첨부문서 : Lab_pre IR_JH Lee.pdf
[Project Leader : Jeong-Ho Lee Organization : KAIST]
1. Human Genetics
4. Discovery of drug target & Drug-repositioning
1.Discovery of new therapeutic target for FCD related epilepsy in patients
2.Generation of model mouse with identified mutation
Stage of Research
Phase III Clinical trial for the drug-repositioning of the previously FDA-approved mTOR inhibitor as a cancer drug by a global pharmaceutical company.